MAINZ BIOMED N.V. ($MYNZ) Insider Transactions

Last updated: 2026-03-16 13:06 UTC | Total transactions: 9

In the last 12 months, insiders at MAINZ BIOMED N.V. ($MYNZ) filed 9 transactions with the SEC: 2 open-market purchases totaling $1,436,350 and 0 sales totaling $0. Net insider sentiment: net buying.

MAINZ BIOMED N.V. operates in the Pharmaceutical preparations industry (Life sciences sector).

Most Active Insiders

View all SEC Filings for MAINZ BIOMED N.V. (MYNZ).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 13, 2026 Lazar David E. Director A Series A Preferred Shares 1000000 $0.00 1,000,000.0000 2,319,353 9999.99% 43.12%
Feb. 13, 2026 Lazar David E. Director A Series B Preferred Shares 1000000 $0.00 1,000,000.0000 2,319,353 9999.99% 43.12%
Feb. 13, 2026 Lazar David E. Director A Series C Preferred Shares 1000000 $0.00 1,000,000.0000 2,319,353 9999.99% 43.12%
Feb. 13, 2026 Caragol William J Chief Financial Officer A Ordinary Shares 290000 $0.00 367,899.0000 2,319,353 372.28% 12.50%
Feb. 13, 2026 Dreismann Heinrich Director A Ordinary Shares 45000 $0.00 64,700.0000 2,319,353 228.43% 1.94%
Feb. 13, 2026 Tibbitts Gregory J Director A Ordinary Shares 45000 $0.00 55,875.0000 2,319,353 413.79% 1.94%
Feb. 13, 2026 BAECHLER GUIDO Chief Executive Officer A Ordinary Shares 440000 $0.00 605,058.0000 2,319,353 266.57% 18.97%
Oct. 17, 2025 Donahue Kevin Michael TenPercentOwner P Common Stock 685000 $1.51 685,000.0000 2,319,353 9999.99% 29.53%
Oct. 17, 2025 Donahue Kevin Michael TenPercentOwner P Common Stock 643850 $402000.00 643,850.0000 2,319,353 9999.99% 27.76%